Amgen and Arrakis collaborate to discover and develop targeted RNA degrader therapeutics Jan. 12, 2022
Mydecine completes model of new serotonin receptor for AI-driven drug discovery program Jan. 11, 2022
Amarna and Redoxis receive grant to support ALPHAVAC project in neurodegenerative diseases Jan. 11, 2022
RSS